ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,133,052 | -26.1% | 103,475 | -10.7% | 0.00% | – |
| Q2 2023 | $1,534,040 | -28.5% | 115,864 | -26.5% | 0.00% | – |
| Q1 2023 | $2,145,344 | -76.8% | 157,630 | -66.6% | 0.00% | -100.0% |
| Q4 2022 | $9,228,218 | +40.0% | 472,515 | +36.6% | 0.00% | 0.0% |
| Q3 2022 | $6,592,000 | +112.9% | 346,020 | +130.3% | 0.00% | – |
| Q2 2022 | $3,096,000 | -31.1% | 150,246 | +7.6% | 0.00% | – |
| Q1 2022 | $4,491,000 | +8.3% | 139,579 | +56.7% | 0.00% | – |
| Q4 2021 | $4,146,000 | +586.4% | 89,058 | +298.2% | 0.00% | – |
| Q3 2021 | $604,000 | +197.5% | 22,364 | +182.5% | 0.00% | – |
| Q2 2021 | $203,000 | -3.8% | 7,916 | +28.4% | 0.00% | – |
| Q1 2021 | $211,000 | +276.8% | 6,163 | +272.6% | 0.00% | – |
| Q4 2020 | $56,000 | +12.0% | 1,654 | -18.4% | 0.00% | – |
| Q3 2020 | $50,000 | – | 2,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |